ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 3:59 PM
17.00
0.29%
After-hours: Aug 15, 2025, 07:08 PM EDT

ADMA Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
90.28M 71.63M 103.15M 86.71M 88.24M 45.33M 51.35M 74.16M 62.51M 69.2M 86.52M 34.91M 52.42M 69.5M 51.09M 34.41M 42.41M 61.97M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
9.06M 16.21M 5.66M 14.72M 5.22M 5.89M 4.67M 6.72M 6.29M 4.72M 4.77M 4.46M 3.76M 2.83M 4.07M 3.33M 2.53M 2.22M
Receivables
109.73M 99.41M 50M 50.14M 30.11M 49.62M 27.42M 31.32M 36.73M 26.52M 15.51M 20.9M 18.88M 25.63M 28.58M 20.39M 23.54M 15.36M
Inventory
191.46M 172.19M 170.24M 171.8M 179.81M 177.73M 172.91M 163.12M 161.78M 163.98M 163.28M 162.91M 146.08M 139.15M 124.72M 114.12M 99.7M 94.15M
Other Current Assets
8.09M 8.59M 8.03M 9.54M 5.52M 3.74M 5.33M 5.11M 5.22M 4.38M 5.09M 5.37M 5.4M 5.52M n/a 5.86M 5.7M 5.8M
Total Current Assets
399.56M 351.81M 331.41M 318.19M 303.69M 276.42M 257.01M 273.7M 266.24M 264.09M 270.4M 224.09M 222.77M 239.8M 208.73M 174.79M 171.36M 177.28M
Property-Plant & Equipment
66.46M 57.71M 63.34M 53.69M 63.48M 64.71M 63.47M 64.57M 66.31M 67.62M 68.75M 67.28M 65.5M 60.33M 58.2M 55.08M 53.32M 50.37M
Goodwill & Intangibles
4.06M 3.98M 3.99M 4.01M 4.01M 3.85M 4.03M 4.01M 4.19M 4.36M 4.54M 4.72M 4.9M 5.08M 5.26M 5.44M 5.62M 5.79M
Total Long-Term Assets
158.82M 158.75M 157.27M 72.42M 72.71M 74.46M 72.17M 75.3M 76.78M 76.7M 78.06M 76.46M 74.16M 68.23M 67.52M 63.86M 61.46M 58.39M
Total Assets
558.38M 510.57M 488.68M 390.62M 376.4M 350.88M 329.18M 349M 343.03M 340.79M 348.46M 300.56M 296.93M 308.03M 276.25M 238.64M 232.81M 235.67M
Account Payables
29.77M 20.61M 20.22M 16.02M 14.18M 17.19M 15.66M 10.85M 12.08M 12.96M 13.23M 25.2M 11.39M 14.12M 12.43M 17.28M 6.17M 12.15M
Deferred Revenue
143K 143K 143K 143K 1.13M 1.12M 182K 142.83K 142.83K 142.83K 143K 142.83K 142.83K 142.83K 142.83K 142.83K 142.83K 142.83K
Short-Term Debt
n/a 1.19M 1.22M n/a 1.14M 1.09M n/a 982.89K 979.54K 956.04K n/a 720.75K 579.66K 654K n/a 501.24K 385.86K 317.91K
Other Current Liabilities
17.49M 31.56M 1.85M 3.31M 1.15M 30.75M 30.72M 27.06M 25.09M 19.97M 1.8M 16.11M 14.36M 13.79M 16.05M 9.75M 8.87M 6.17M
Total Current Liabilities
74.94M 53.5M 55.54M 44.89M 44.18M 53.09M 49.81M 41.84M 41.95M 36.73M 39.27M 44.44M 28.07M 31.57M 30.38M 32.34M 18.19M 21.21M
Long-Term Debt
73.4M 80.83M 72.34M 101.33M 131.07M 130.85M 130.59M 142.03M 140.31M 144.3M 142.83M 141.37M 139.81M 138.42M 94.87M 94.36M 93.88M 93.41M
Other Long-Term Liabilities
940K 2.83M 3.22M 3.65M 2.08M 2.09M 2.11M 2M 2.02M 1.84M 1.85M 1.86M 1.87M 1.89M 397.35K 232.66K 36.15K 41.97K
Total Long-Term Liabilities
85.11M 83.65M 84.12M 113.84M 143.95M 144.08M 144.17M 155.72M 154.31M 158.41M 157.22M 155.73M 154.46M 149.53M 104.7M 103.52M 103.03M 101.96M
Total Liabilities
160.06M 137.15M 139.66M 158.73M 188.13M 197.17M 193.98M 197.56M 196.26M 195.13M 196.49M 200.17M 182.53M 181.1M 135.08M 135.86M 121.22M 123.16M
Total Debt
83.83M 82.01M 82.12M 111.38M 141.4M 141.43M 141.42M 152.97M 151.51M 155.73M 154.44M 152.72M 151.26M 146.36M 102.92M 101.78M 101.34M 100.15M
Common Stock
24K 24K 24K 24K 23K 23K 23K 22.6K 22.45K 22.23K 22K 19.68K 19.64K 19.64K 19.58K 13.83K 13.19K 12.3K
Retained Earnings
-247.46M -281.68M -308.58M -420.48M -456.39M -488.45M -506.26M -488.61M -491.18M -484.81M -478.02M -465.78M -450.89M -437.12M -412.11M -395.46M -377.75M -358.85M
Comprehensive Income
n/a n/a n/a n/a -0.00 -0.00 n/a n/a n/a n/a n/a n/a n/a 0.00 n/a n/a -0.00 n/a
Shareholders Equity
398.32M 373.42M 349.02M 231.89M 188.27M 153.71M 135.21M 151.44M 146.76M 145.65M 151.97M 100.38M 114.4M 126.93M 141.17M 102.78M 111.59M 112.5M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a